MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$32,932K
EPS
-$0.41
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
28,150
41,134
42,090*
38,347
General and administrative
6,949
6,874
8,428*
7,220
Total operating expenses
35,099
48,008
50,518
45,567
Loss from operations
-35,099
-48,008
-50,518*
-45,567
Interest income and other, net
2,190
2,618
4,219*
3,714
Loss before income taxes
-32,909
-45,390
-46,300*
-41,853
Income tax expense
24
50
-6,766*
196
Net loss
-32,933
-45,440
-39,534*
-42,049
Unrealized gain (loss) on available-for-sale investments
1
-271
-239*
201
Comprehensive loss
-32,932
-45,711
-39,773
-41,848
Basic EPS
-0.41
-0.57
-0.487
-0.53
Diluted EPS
-0.41
-0.57
-0.487
-0.53
Basic Average Shares
80,050,518
79,198,204
81,686,567
79,052,154
Diluted Average Shares
80,050,518
79,198,204
81,686,567
79,052,154
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$32,932K
(11.57%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale investments
$1K
(101.23%↑ Y/Y)
Net loss
-$32,933K
(11.38%↑ Y/Y)
Loss before income
taxes
-$32,909K
(10.95%↑ Y/Y)
Income tax expense
$24K
(-88.41%↓ Y/Y)
Interest income and
other, net
$2,190K
(-50.13%↓ Y/Y)
Loss from operations
-$35,099K
(15.11%↑ Y/Y)
Total operating
expenses
$35,099K
(-15.11%↓ Y/Y)
Research and development
$28,150K
(-12.78%↓ Y/Y)
General and
administrative
$6,949K
(-23.38%↓ Y/Y)
Buy us a coffee
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)